Showing results (51-60 of 111) with videos related to
Sort By:
Pageof 12
The Journal of Clinical Investigation|June 1, 1994
In vivo effects of IgA and IgG2a anti-CD3 isotype switch variantsK J Parlevliet, I J ten Berge, S L Yong, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Low-dose OKT3 induction therapy following renal transplantation: a controlled studyK J Parlevliet, R J ten Berge, M H Raasveld, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Guidelines for the optimal use of muromonab CD3 in transplantationI J ten Berge, K J Parlevliet, M H Raasveld, et al.The Journal of Clinical Investigation|July 1, 1990
Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected menC J van Noesel, R A Gruters, F G Terpstra, et al.The Journal of Laboratory and Clinical Medicine|December 1, 1995
Biphasic granulocytopenia after administration of the first dose of OKT3F J Bemelman, S Buysmann, S L Yong, et al.European Journal of Immunology|April 1, 1989
Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infectionF G Terpstra, B J Al, M T Roos, et al.Photochemistry and Photobiology|January 1, 1997
Extracorporeal photochemotherapy (photopheresis) induces apoptosis in lymphocytes: a possible mechanism of action of PUVA therapyD N Enomoto, P T Schellekens, S L Yong, et al.Clinical and Experimental Immunology|February 1, 1995
Effects of anti-CD3 monoclonal antibodies on functional activity of lymphocytes: studies in vivo and in vitroK J Parlevliet, M E Chamuleau, S L Yong, et al.European Journal of Immunology|May 1, 1989
The influence of cyclosporin A on the alternative pathways of human T cell activation in vitroE Bloemena, R H Van Oers, S Weinreich, et al.Transplant Immunology|January 1, 1994
Sequestration of labelled granulocytes in the lungs following administration of OKT3 is dose-dependentF J Bemelman, K J Parlevliet, P T Schellekens, et al.Pageof 12